hat
Dianabol reprezante youn nan estewoyid yo sèlman anabolik ki te devlope pou objektif la sèl nan amelyorasyon pèfòmans. Konpoze an te pote ki nan lis itilizasyon ki ka geri nan yon sèl fwa, men pèfòmans te vrè rezon sa a esteroyid te bay lavi. Atravè ane 1940 yo ak 50 nan Inyon Sovyetik yo te kòmanse domine jwèt yo Olympic, ak itilize nan testostewòn pa anpil nan atlèt li yo kite rès la nan mond lan lagging byen lwen dèyè. Pandan tan sa a, US Olympic ekip Dr Jan Ziegler ta aprann nan itilize esteroyid USSR a, epi byen vit ta èd nan asire atlèt l 'yo ta matche ak moute. An 1958, avèk èd nan Dr. Ziegler, Ciba Pharmaceuticals ta lage premye lo nan Methandrostenolone anba non komès Dianabol la. Te konpoze an ki fèt nan yon efò yo kenbe pwopriyete yo anabolizan nan testostewòn ak mwens Androjenik nan yon vit aji, pwisan metòd. Sanble lannwit lan esteroyid la se te yon siksè masiv, ki bay anpil atlèt US yon avantaj diferan sou rival Sovyetik yo.
eng
Dianabol represents one of the only anabolic steroids that was developed for the sole purpose of performance enhancement. The compound did carry listed therapeutic uses at one time, but performance was the true reason this steroid was given life. Through the 1940’s and 50’s the Soviet Union had begun to dominate the Olympic games, and the use of testosterone by many of its athletes left the rest of the world lagging far behind. During this time, U.S. Olympic team Dr. John Ziegler would learn of the U.S.S.R.’s steroid use, and quickly would aid in ensuring his athletes would match up. In 1958, with the help of Dr. Ziegler, Ciba Pharmaceuticals would release the first batches of Methandrostenolone under the trade name Dianabol. The compound was designed in an effort to maintain the anabolic properties of testosterone with less androgenicity in a fast acting, powerful method. Seemingly overnight the steroid was a massive success, giving many U.S. athletes a distinct advantage over their Soviet rivals.